Vaxcyte, Inc. (PCVX) Misses Q2 EPS by 5c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.22), $0.05 worse than the analyst estimate of ($1.17).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Kepler Cheuvreux Downgrades Thyssenkrupp Nucera AG (NCH2:GR) to Hold
• MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
• Palo Alto Networks (PANW) Reiterated at Market Outperform by Citizens on Platformization